BCAB Earnings
Latest Revenue6.5M
Latest Net Income452.0K
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.27 | 6.5M | 452.0K | — | +101.7% |
| Q1 2026 | -$4.22 | 0 | -6344000 | — | +67.9% |
| Q4 2025 | -$2.81 | 2.0M | -9784000 | — | +81.3% |
| Q3 2025 | -$13.50 | 0 | -15778000 | -100.0% | -22.7% |
| Q2 2025 | -$15.99 | 0 | -18711000 | — | +27.3% |
| Q1 2025 | -$13.16 | 0 | -15334000 | — | +45.2% |
| Q4 2024 | -$14.99 | 0 | -14884000 | — | +46.6% |
| Q3 2024 | -$11.00 | 11.0M | -10586000 | — | +68.6% |
| Q2 2024 | -$22.00 | 0 | -21072000 | — | — |
| Q1 2024 | -$24.00 | 0 | -23234000 | — | — |
| Q4 2023 | -$28.05 | 0 | -26925000 | — | — |
| Q3 2023 | -$35.00 | 0 | -33325000 | — | — |
BioAtla (BCAB) — Earnings